Acta Med. 2004, 47: 133-136

The Angiotensin Converting Enzyme I/D Polymorphism in Turkish Athletes and Sedentary Controls

Günfer Turguta,b, Sebahat Turguta,b, Osman Gença,b, Ayfer Atalayb,c, Erol Ömer Atalayb,c

aPamukkale University, Medical Faculty, Department of Physiology, Denizli, Turkey
bPamukkale University Research Center for Genetic Engineering and Biotechnology (PAMGEN), Denizli, Turkey
cPamukkale University, Medical Faculty, Department of Biophysics, Denizli, Turkey

Received December 1, 2003
Accepted April 1, 2004


1. Akar N, Aras O, Omürlü K et al. Deletion polymorphism at the angiotensin-converting enzyme gene in Turkish patients with coronary artery disease. Scand J Clin Lab Invest 1998; 58:491–5. <>
2. Alvarez R, Reguero JR, Batalla A et al. Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphisms: association with early coronary disease. Cardiovasc Res 1998; 40:375–9. <>
3. Alvarez R, Terrados N, Ortolano R et al. Genetic variation in the rennin-angiotensin system and athletic performance. Eur J Appl Physiol 2000; 82:117–20. <>
4. Araz M, Yilmaz N, Güngör K et al. Angiotensin-converting enzyme gene polymorphism and microvascular complications in Turkish type 2 diabetic patients. Diabetes Res Clin Pract 2001; 54:95–104. <>
5. Baudin B. New aspect on angiotensin-converting enzyme: from gene to disease. Clin Chem Lab Med 2002; 40:256–65. <>
6. Baudin B, Berard M, Carrier JL et al. Vascular origin determines angiotensin I-converting expression in endothelial cells. Endothelium 1997; 5:73–84. <>
7. Bedir A, Arik N, Adam B et al. Angiotensin converting enzyme gene polymorphism and activity in Turkish patients with essential hypertension. Am J Hypertens 1999; 12:1038–43. <>
8. Butler R, Morris AD, Burchell B et al. DD angiotensin-converting enzyme gene polymorphism is associated with endothelial dysfunction in normal humans. Hypertension 1999; 33:1164–8. <>
9. Danser AH, Schalekamp MA, Bax WA et al. Angiotensin converting enzyme in the human heart: effect of the deletion/insertion polymorphism. Circulation 1995; 92:1387–8. <>
10. Foy CA, Rice GI, Ossey-Gerning N et al. Angiotensin converting enzyme (ACE) gene polymorphisms in patients characterized by coronary angiography. Hum Genet 1997; 100:420–5. <>
11. Gayagay G, Yu B, Hambly B et al. Elite endurance athletes and the ACE I allele. The role of genesis in athletic performance. Hum Genet 1998; 103:48–50. <>
12. Hagberg JM, Ferrell RE, McCole S et al. VO2 max is associated with ACE genotype in postmenopausal women. J Appl Physiol 1998; 85:1842–6. <>
13. Isbir T, Yilmaz H, Agachan B et al. Association between angiotensin-converting enzyme gene polymorphism and coronary artery disease. IUBMB Life 1999; 48:205–7. <>
14. Krizanová O, Obdrzálková D, Poláková H et al. Molecular variants of the reninangiotensin system components in the Slovak population. Physiol Res 1997; 46:357–61.
15. Mattu RK, Needham EWA, Galton DJ et al. A DNA variant at the angiotensinconverting enzyme gene locus associates with coronary artery disease in the Caerphilly heart study. Circulation 1995; 91:270–4. <>
16. McKinley MJ, Allen AM, Mathai ML et al. Brain angiotensin and body fluid homeostasis. Jpn J Physiol 2001; 51:281–9. <>
17. Montgomery HE, Clarkson P, Barnard M et al. Angiotensin-converting enzyme gene insertion/deletion polymorphism and response to physical training. Lancet 1999; 353:541–5. <>
18. Montgomery HE, Clarkson P, Dollery CM et al. Association of Angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation 1997; 96:741–7. <>
19. Montgomery HE, Marshall RM, Hemingway H et al. Human gene for physical performance. Nature 1998; 393:221–2. <>
20. Myerson S, Hemingway H, Budget R et al. Human angiotensin I-converting enzyme gene and endurance performance. J Appl Physiol 1999; 87:1313–6. <>
21. Nazarov IB, Woods DR, Montgomery HE et al. The angiotensin converting enzyme I/D polymorphism in Russian athletes. Eur J Hum Genet 2001; 9:797–801. <>
22. Ponez M, Solowiejczky D, Harpel B et al. Construction of human gene libraries from small amounts of peripheral blood. Hemoglobin 1982; 6:27–36.
23. Rankinen T, Wolfarth B, Simoneau JA et al. No association between the angiotensin- converting enzyme ID polymorphism and elite endurance athlete status. J Appl Physiol 2000; 88:1571–5. <>
24. Rigat B, Hubert C, Alhenc-Gelas F et al. An insertion/deletion polymorphism in the angiotensin-1–converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86:1343–6. <> <PubMed>
25. Rigat B, Tiret L, Visvikis S et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992; 51:197–205.
26. Soubrie F, Hubert C, Testut P et al. Molecular biology of the angiotensin I converting enzyme, I: biochemistry and structure of the gene. J Hypertens 1993; 11:471–6. <>
27. Taylor RR, Mamotte CDS, Fallon K et al. Elite athletes and the gene for angiotensin- converting enzyme. J Appl Physiol 1999; 87:1035–7. <>
28. Villard E, Soubrier F. Molecular biology and genetics of the angiotensin I-converting enzyme: potential implications in cardiovascular diseases. Cardiovasc Res 1996; 32:999–1007. <>
29. Wang XL, McCredie RM, Wilcken DEL. Genotype distribution of angiotensinconverting enzyme polymorphism in Australian healthy and coronary populations and relevance to myocardial infarction and coronary artery disease. Arterioscler Thromb Vasc Biol 1996; 16: 115–9. <>
30. Williams AG, Rayson MP, Jubb M et al. The ACE gene and muscle performance. Nature 2000; 403:614. <>
31. Woods DR, Humphries SE, Montgomery HE. The ACE I/D polymorphism and human physical performance. Trends Endocrinol Metab 2000; 11:416–20. <>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal